115 related articles for article (PubMed ID: 7954937)
1. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. IV. 2-[2-(1-Imidazolyl)ethyl]-4-(3-pyridyl)-1(2H)-phthalazinones.
Yamaguchi M; Koga T; Kamei K; Akima M; Maruyama N; Kuroki T; Hamana M; Ohi N
Chem Pharm Bull (Tokyo); 1994 Sep; 42(9):1850-3. PubMed ID: 7954937
[TBL] [Abstract][Full Text] [Related]
2. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. III. 4-[2-(5-ethyl-2-thienyl)]-2'-[2-(1-imidazolyl)ethyl]-1(2H)- phthalazinones.
Yamaguchi M; Koga T; Kamei K; Akima M; Kuroki T; Hamana M; Ohi N
Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1601-4. PubMed ID: 7954911
[TBL] [Abstract][Full Text] [Related]
3. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 1. 2-[2-(1-Imidazolyl)alkyl]-1(2H)-phthalazinones.
Yamaguchi M; Kamei K; Koga T; Akima M; Kuroki T; Ohi N
J Med Chem; 1993 Dec; 36(25):4052-60. PubMed ID: 8258827
[TBL] [Abstract][Full Text] [Related]
4. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 2. 4-(3-Pyridyl)-1(2H)-phthalazinones.
Yamaguchi M; Kamei K; Koga T; Akima M; Maruyama A; Kuroki T; Ohi N
J Med Chem; 1993 Dec; 36(25):4061-8. PubMed ID: 8258828
[TBL] [Abstract][Full Text] [Related]
5. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. V. Thienopyridazinone derivatives.
Yamaguchi M; Maruyama N; Koga T; Kamei K; Akima M; Kuroki T; Hamana M; Ohi N
Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):236-40. PubMed ID: 7728930
[TBL] [Abstract][Full Text] [Related]
6. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. VI. Indazole derivatives.
Yamaguchi M; Maruyama N; Koga T; Kamei K; Akima M; Kuroki T; Hamana M; Ohi N
Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):332-4. PubMed ID: 7728936
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and thromboxane A2 antagonistic activity of [[1-aryl(or benzyl)-1-(benzenesulfonamido)methyl]phenyl]alkanoic acid derivatives.
Sakurai S; Ogawa N; Suzuki T; Kato K; Ohashi T; Yasuda S; Kato H; Ito Y
Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):765-77. PubMed ID: 8681409
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of [[(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives containing pyridyl or imidazolyl groups and their thromboxane A2 receptor antagonistic and thromboxane A2 synthase inhibitory activities.
Sakurai S; Ogawa N; Suzuki T; Kato K; Ohashi T; Yasuda S; Kato H
Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1510-20. PubMed ID: 8795270
[TBL] [Abstract][Full Text] [Related]
9. 1-imidazolyl(alkyl)-substituted di- and tetrahydroquinolines and analogues: syntheses and evaluation of dual inhibitors of thromboxane A(2) synthase and aromatase.
Jacobs C; Frotscher M; Dannhardt G; Hartmann RW
J Med Chem; 2000 May; 43(9):1841-51. PubMed ID: 10794700
[TBL] [Abstract][Full Text] [Related]
10. Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma.
Takami M; Takata Y; Matsumoto K; Ono S; Tsukada W
Ann N Y Acad Sci; 1991; 629():407-9. PubMed ID: 1952565
[No Abstract] [Full Text] [Related]
11. Synthesis and dual antagonistic activity against thromboxane A2 and leukotriene D4 of [4-[1-(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives.
Sakurai S; Ogawa N; Onogi Y; Takeshita M; Takahashi H; Ohashi T; Kato K; Yasuda S; Kato H
Chem Pharm Bull (Tokyo); 1997 May; 45(5):849-62. PubMed ID: 9178522
[TBL] [Abstract][Full Text] [Related]
12. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
Ford NF; Browne LJ; Campbell T; Gemenden C; Goldstein R; Gude C; Wasley JW
J Med Chem; 1985 Feb; 28(2):164-70. PubMed ID: 3918169
[TBL] [Abstract][Full Text] [Related]
13. Dibenzoxepin derivatives: thromboxane A2 synthase inhibition and thromboxane A2 receptor antagonism combined in one molecule.
Ohshima E; Sato H; Obase H; Miki I; Ishii A; Kawakage M; Shirakura S; Karasawa A; Kubo K
J Med Chem; 1993 May; 36(11):1613-8. PubMed ID: 8496929
[TBL] [Abstract][Full Text] [Related]
14. 7-(Ethoxycarbonyl)-6,8-dimethyl-2-phenyl-1(2H)-phthalazinone derivatives: synthesis and inhibitory effects on platelet aggregation.
Sugimoto A; Tanaka H; Eguchi Y; Ito S; Takashima Y; Ishikawa M
J Med Chem; 1984 Oct; 27(10):1300-5. PubMed ID: 6090662
[TBL] [Abstract][Full Text] [Related]
15. Imidazol-1-yl and pyridin-3-yl derivatives of 4-phenyl-1,4-dihydropyridines combining Ca2+ antagonism and thromboxane A2 synthase inhibition.
Cozzi P; Carganico G; Fusar D; Grossoni M; Menichincheri M; Pinciroli V; Tonani R; Vaghi F; Salvati P
J Med Chem; 1993 Oct; 36(20):2964-72. PubMed ID: 8411014
[TBL] [Abstract][Full Text] [Related]
16. Selective thromboxane synthetase inhibitors. 2. 3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indole-1-propanoic acid and analogues.
Cross PE; Dickinson RP; Parry MJ; Randall MJ
J Med Chem; 1986 Mar; 29(3):342-6. PubMed ID: 3081722
[TBL] [Abstract][Full Text] [Related]
17. Studies on anti-platelet agents. II. Synthesis and platelet-inhibitory activity of 5-methyl-4-(3-pyridyl)-2-(substituted benzimidazol-5-yl)imidazoles.
Tanaka A; Ito K; Nishino S; Motoyama Y; Takasugi H
Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):560-9. PubMed ID: 8004701
[TBL] [Abstract][Full Text] [Related]
18. Studies on antiplatelet agents. I. Synthesis and platelet inhibitory activity of 5-alkyl-2-aryl-4-pyridylimidazoles.
Tanaka A; Ito K; Nishino S; Motoyama Y; Takasugi H
Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3206-13. PubMed ID: 1294322
[TBL] [Abstract][Full Text] [Related]
19. Correlative alteration of thromboxane A2 with antigen-induced bronchoconstriction and the role of platelets as a source of TXA2 synthesis in guinea pigs: effect of DP-1904, an inhibitor of thromboxane synthetase.
Takami M; Tsukada W
Pharmacol Res; 1998 Aug; 38(2):133-9. PubMed ID: 9721601
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
Tobias LD; Hamilton JG
Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
